Literature DB >> 19626751

A pilot of the Parents' Evaluation of Developmental Status tool.

Sue Davies1, Helen Feeney.   

Abstract

Between February and July 2006, Milton Keynes health visitors piloted the Parents' Evaluation of Developmental Status (PEDS), inviting every two-year-old (n=100) living in the Sure Start Local Programme area for a review of their health and development. PEDS is a validated tool that assists in the identification and prediction of developmental, behavioural and social or emotional issues in children from birth to eight years. This tool was also highlighted by 'Health for all children' as one for possible use. The pilot showed evidence that it was beneficial in identifying current developmental, behavioural and social or emotional issues, promoting communication between parents, departments and other agencies, developing a clear pathway of care to ensure appropriate and timely referral and follow up, and increasing parental satisfaction with the child health review. The predictive element of PEDS has yet to be corroborated by our pilot, as children are still being followed up. With parents' signed permission, information about the results of their child's health review is shared with other statutory and voluntary agencies so that where issues are identified, activities can be started in order to minimise the likelihood of developmental delay in any specific area.

Entities:  

Mesh:

Year:  2009        PMID: 19626751

Source DB:  PubMed          Journal:  Community Pract        ISSN: 1462-2815


  2 in total

1.  Diagnostic Accuracy of Parents' Evaluation of Developmental Status (PEDS), PEDS Developmental Milestones, and PEDS Combined in Indian Children Aged Less than 2 Years.

Authors:  Sharmila Banerjee Mukherjee; Sangeeta Verma; Suvasini Sharma; Satinder Aneja
Journal:  Indian J Pediatr       Date:  2021-02-23       Impact factor: 1.967

Review 2.  A systematic review of the prevalence of parental concerns measured by the Parents' Evaluation of Developmental Status (PEDS) indicating developmental risk.

Authors:  Susan Woolfenden; Valsamma Eapen; Katrina Williams; Andrew Hayen; Nicholas Spencer; Lynn Kemp
Journal:  BMC Pediatr       Date:  2014-09-13       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.